Had bioprinting been around in Vincent van Gogh’s day, he would have had to do something more dramatic to express his inner torment than cutting off his ear – American startup BioBots has been demonstrating that he could have easily just 3D-printed a new one.
Building living tissues nearly from scratch isn’t a brand new science. Researchers have used lab animals as hosts to grow functioning organs for people in need of transplants and yes, even human ears. Even 3D printing artificial biological material has been around for a few years, using experimental “bio-inks” and designs for printable skin grafts, just for starters.
BioBots seeks to combine the ability of high-end tissue fabrication – which often requires large, expensive machines running into the US$100,000 range that require technicians to operate – with the ethos of the maker movement and more inexpensive desktop 3D printing equipment.
The project began in the dorms of the University of Pennsylvania last year and quickly moved to the DreamIt Health Accelerator in Philadelphia last fall, before winning awards at South By Southwest and TechCrunch Disrupt in the past few months.
In the below video from DreamIt’s demo day, co-founder Danny Cabrera demonstrates how BioBots works. It uses a cartridge technology similar to that of inkjet printers, capable of building up tissues at a resolution of 100 micrometers. That tissue is then rapidly cured using a special blue light that does not damage the cells. The result is a printed ear that van Gogh himself could have used.
This early system sold for just $5,000 to beta version adopters that are providing feedback for the development of the final version.
The Latest on: 3D Bioprinting
via Google News
The Latest on: 3D Bioprinting
- Global 3D Bioprinting Market In-depth Analysis, Competitive Landscape and Future Scope from 2020 to 2025on May 8, 2020 at 2:04 am
The 3D bioprinting market was valued at USD 483.34 million in 2018 and is expected to register a CAGR of 25.36% during the forecast period (2020 - 2025) The global 3D bioprinting market is ...
- Guohao Dai: 3D bioprinted glioblastoma models and 3D imagingon May 5, 2020 at 5:05 am
We developed a 3D bioprinted glioblastoma tumor model, which is the deadliest form of brain tumor. The 3D bioprinting model was developed to mimic the extracellular microenvironment in which we could ...
- Acoustic bioprinting technology helps introduce nerve cells into spherical cage structureon May 4, 2020 at 10:10 pm
Their grid openings are only a few micrometers in size, making them ideal for holding cells and allowing living tissue to grow in a very specific shape. This new field of research is called ...
- How to put neurons into cageson May 4, 2020 at 3:40 am
Nerve cells have now been introduced into spherical cage structures using acoustic bioprinting technology, so that multicellular nerve tissue can develop there.
- 3D Bioprinting Market Size to Exhibit a CAGR of 24.59% By 2023on May 1, 2020 at 6:19 pm
The 3D Bioprinting Market size to attain the a CAGR of 24.59% to get past a valuation of around USD 1,923.02 million by 2023, suggests Market Research Future (MRFR). The growth would get ...
- 3D Printing Medical Devices Market - Anticipated to Witness High Growth in the Near Futureon May 1, 2020 at 9:57 am
According to latest research report " 3D Printing Medical Devices Market by Technology (3DP, EBM, LBM, Photopolymerization and DD), Component (3D Printers, 3D Bioprinters, Material (Plastic, Metal, ...
- 3D Bioprinting Market to Face a Significant Slowdown in 2020, as COVID-19 Sets a Negative Tone for Investorson May 1, 2020 at 1:33 am
May 01, 2020 (MARKITWIRED via COMTEX) -- VALLEY COTTAGE, N.Y. - Spritam (levetiracetam) is the first treatment with 3D bioprinting that gained FDA approval and was developed by Aprecia ...
- South Korea: T&R Biofab Will Use 3D Cell Bioprinting Technology for New Stem Cell Researchon April 30, 2020 at 10:13 pm
3D bioprinting of human tissues and organs has been revolutionizing tissue engineering for several years, helping researchers move past animal models. In fact, many scientists have used the ...
- RASTRUM™- the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazineon April 30, 2020 at 5:53 am
The RASTRUM™ 3D Bioprinter from Inventia Life Science gives medical researchers and biologists the ability to rapidly produce 3D tissues that closely resemble our human body. By ...
- Viscient Biosciences is Leveraging 3D Bioprinting for Drug Discoveryon April 29, 2020 at 12:49 am
The versatile biotechnology company, created a more faithful picture of specific human diseases by relying on human cells and a 3D reconstruction of the tissue to show the truest possible biology ...
via Bing News